Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000908662-14-000290
Filing Date
2014-11-21
Accepted
2014-11-21 16:38:27
Documents
1
Period of Report
2014-11-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4054
  Complete submission text file 0000908662-14-000290.txt   5398
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Issuer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ENANTA PHARMACEUTICALS, INC. 500 ARSENAL STREET WATERTOWN MA 02472
Business Address
Ocain Tim (Reporting) CIK: 0001599020 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35839 | Film No.: 141243512